Table 1 Participant demographics and clinical characteristics.
Age: (years) median (Standard Deviation), Range | 76.5 (4.2), 70–83 |
Sex: Male/Female | 21/30 (70% M) |
Cancer diagnosis | |
Breast | 5 |
Lung | 8 |
Prostate | 3 |
Colorectal | 3 |
Head and Neck | 1 |
Upper gastrointestinal | 10 |
Metastatic cancer | 14 (46.7%) |
Non-metastatic cancer | 16 (53.3%) |
Anthropometrics — Mean, SD, Range, % completion | |
Weight, kg | 76.5 (17.0), 40.9–112.9 |
29/30 (96.7%) | |
Body mass index, kg/m2 | 25.4 (3.5), 16.0–34.6 |
29/30 (96.7%) | |
Mid-arm circumference, cm | 27.6 (4.3), 17.5–34.0 |
28/30 (93.3%) | |
Hand grip strength, kg | 21.8 (7.7), 7.0–39.0 |
26/30 (86.7%) | |
Chair stand test, repeats | 10.4 (4.8), 6–20 |
10/30 (33.3%) | |
Timed up and go test, seconds | 12.4 (3.2), 8.4–16.9 |
9/30 (30%) | |
Appendicular skeletal muscle, kg | 22.5 (4.6), 14.7–32.2 |
(from BIA) | 12/30 (40%) |
Skeletal muscle index, kg/m2 | 7.5 (1.3), 5.6–9.8 |
(from BIA) | 12/30 (40%) |
Biochemical markers — Mean, SD, Range of days from collection, % completion | |
Albumin | 2.3 (2.5), 0–10 days |
29/30 (96.7%) | |
Haemoglobin | 2.2 (1.9), 0–7 days |
29/30 (96.7%) | |
C reactive protein | 3.2 (3.2), 0–11 days |
26/30 (86.7%) | |
Lymphocyte count | 2.2 (1.9), 0–7 days |
28/30 (93.3%) | |
Clinical scales — Mean, SD, Range, % completion | |
Rockwood clinical frailty scale | 3.9 (1.4), 1–9 |
(1—very fit, 9—terminally ill) | 30/30 (100%) |
Charlson comorbidity index | 8.0 (2.4), 5–14 |
(mild 1–2; moderate, 3–4; and severe, ≥5) | 30/30 (100%) |
